Jump to main content
博士論文

Panitumumab provides better survival outcomes compared to cetuximab for metastatic colorectal cancer patients treated with prior bevacizumab within 6 months

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Panitumumab provides better survival outcomes compared to cetuximab for metastatic colorectal cancer patients treated with prior bevacizumab within 6 months

Persistent ID (NDL)
info:ndljp/pid/11674181
Material type
博士論文
Author
奥野, 香里
Publisher
奥野, 香里
Publication date
2021
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
日本大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
奥野, 香里
Publication, Distribution, etc.
Publication Date
2021
Publication Date (W3CDTF)
2021
Alternative Title
ベバシズマブ投与後6ヶ月未満の切除不能進行再発大腸がん患者における抗EGFR抗体薬の選択に関する検討
Degree grantor/type
日本大学
Date Granted
2021-03-25
Date Granted (W3CDTF)
2021-03-25